TFC Financial Management, Inc.
Position in ABOS — Acumen Pharmaceuticals, Inc.
CIK 1827844
BOSTON, MA
Position in ABOS
as of Mar 31, 2026
· filed Apr 23, 2026
Position Value
$5,900
+$625 QoQ
Shares Held
2,500
0.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#67
of 84 holders
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in ABOS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026TFC Financial Management, Inc. holds $402,102 across 44 Biotechnology names. ABOS ranks #11 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
307 | $137,087 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
104 | $80,354 | |
| 3 | CRSP |
CRISPR Therapeutics AG
|
688 | $32,728 | |
| 4 | TNGX |
Tango Therapeutics, Inc.
|
1,550 | $32,426 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
72 | $23,822 | |
| 6 | MRNA |
Moderna, Inc.
|
319 | $16,205 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
211 | $13,636 | |
| 8 | OCUL |
Ocular Therapeutix, Inc
|
1,352 | $11,451 |
All Filings in ABOS
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,900 | 2,500 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $5,275 | 2,500 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $4,275 | 2,500 | Shares | Sole | 2025-10-24 | |
| No filing history on record for this holder in this stock. | ||||||